ALDOA anticorps (N-Term)

N° du produit ABIN629801

L’anticorps Lapin Polyclonal anti-ALDOA a été validé pour WB. Il convient pour détecter ALDOA dans des échantillons de Humain.

Aperçu rapide pour ALDOA anticorps (N-Term) (ABIN629801)

Antigène: ALDOA (Aldolase A, Fructose-Bisphosphate (ALDOA))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ALDOA est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-ALDOA anticorps

Épitope: N-Term

Specificité: ALDOA antibody was raised against the N terminal of ALDOA

Purification: Purified

Immunogène: ALDOA antibody was raised using the N terminal of ALDOA corresponding to a region with amino acids MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTE

Information d'application

Indications d'application: WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

ALDOA Blocking Peptide, (ABIN5612015), is also available for use as a blocking control in assays to test for specificity of this ALDOA antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALDOA antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur ALDOA

Antigène: ALDOA (Aldolase A, Fructose-Bisphosphate (ALDOA))

Autre désignation: ALDOA

Sujet: ALDOA is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Aldolase A is found in the developing embryo and is produced in even greater amounts in adult muscle. Aldolase A expression is repressed in adult liver, kidney and intestine and similar to aldolase C levels in brain and other nervous tissue. Aldolase A deficiency has been associated with myopathy and hemolytic anemia.

Poids moléculaire: 39 kDa (MW of target protein)

Pathways: Ribonucleoside Biosynthetic Process